Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Glad my house burnt down 4 years ago.... Didn't need a home equity loan... Just used some insurance settlement money to buy some more pphm.... And still had plenty to build a new house!
Lol... Someones playing games! http://www.nasdaq.com/symbol/pphm/premarket
Lol.... Pulling straws..... Nice.
Why even bother replying?? We've been put down for 2 years now... Us longs deserve better than this... We are getting closer and closer....Soon some board members will disappear into the sunset after seeing the sunrise... Can't wait!!
I like your post gull... Sounds perfect to me!
#3... It's not the end of 2015 yet.
Yeah, every company in the IBB too?... That's been dropping also... Clueless.
That was a very warm and heart felt post... Very sad knowing someone is going thru this and knowing it's almost time... Tears.
That's gotta be the saddest thing I've ever read... Krakonos, I am so sorry to hear this! I've always enjoyed reading your post, as I did with Terry Dyes on the SI board... Please stick around we need you.... We don't need another fallen hero. :(
Wooks deep V... Well done. :)
Return email from IR....
Hi Jim,
Steve did attend the conference yesterday. He was an expert on a panel entitled Under-Discovered OncoInnovators. Given the significant number of companies under coverage by Piper, companies were allowed either a standard company presentation or participation on a panel. The panel was the much preferable option for Peregrine as it showcased the company alongside the industry's leading immuno-oncology companies. The interactive format was also a plus as the standard corporate presentation has been heard many times and in many forums before. Unfortunately, the panel was not webcast.
Best,
Stephanie
Well never see $1.17 again! eom
Thanks RR.... We'll see if I still get a reply.
So the OPDIVO/Docetaxel trial enrolled the same amount of patients we have or are in the process of having, give or take a few?
Advanced Non-Squamous NSCLC Trial
In a clinical trial of 582 patients whose advanced non-squamous NSCLC had spread or grown after treatment with platinum-based chemotherapy, 292 were treated with OPDIVO, 290 were treated with chemotherapy (docetaxel). OPDIVO was shown to reduce the risk of dying by 27% compared to chemotherapy (docetaxel). Half of the patients on OPDIVO were still alive at 12.2 months, compared to 9.4 months with chemotherapy (docetaxel). Additionally, OPDIVO was shown to partially or completely shrink tumors in 19% of patients, compared to 12% with chemotherapy (docetaxel). There was no difference between the two treatments in the length of time that patients lived without their tumors worsening.
I just sent IR an email asking if he did.... Hopefully know today.
Looks to be on it's way thou... Both are holding up in a somewhat down day.
Pphmp up a buck... Hmmm. eom
No PM trades this morning?.... Maybe gonna give a little back today... OR NOT! :)
Great post north... eom.
God bless his soul, but the late Dr. Phillip Thorp passes away and his research into PS targeting hasn't ended... I really think the research with Bavi & PS targeting in infectious diseases probably hasn't ended either... I think there is still a lot of calibrations going on behind the curtain in this arena...
Refresh your memories.... http://ir.peregrineinc.com/releasedetail.cfm?ReleaseID=414351
2009 PR.... Peregrine Pharmaceuticals Forms Anti-Viral Research Group to Oversee Its Anti-PS Infectious Disease Collaborations
- New Anti-Viral Research Group to Coordinate and Expand Externally Funded Collaborations Assessing Peregrine's Broad-Spectrum PS-Targeting Antibodies as Potential Anti-Infective Therapies, Vaccines and Topical Preventatives -
- Peregrine's PS-Targeting Anti-Viral Platform Is Being Studied at More than a Dozen Leading Research Institutions with Over $60 Million in Potential Funding Already in Place from TMTI, NIAID, the Gates Foundation and the UC System -
- Broad-Spectrum PS-Targeting Antibodies Have Shown Promise in Life-Threatening Infectious Diseases Including HCV, HIV, CMV, Viral Hemorrhagic Fevers and Leishmaniasis -
Jeez, what's Bavi gonna be used for everything? $$$$$$$
Great strategy!! Let's hope you get in at the 3-4 dollar range and not the $1.30's...
Details of Peregrine’s Piper Jaffray conference participation are as follows:
Conference: Piper Jaffray 27th Annual Healthcare Conference
Date: December 1-2, 2015
Panel Title: Under-Discovered OncoInnovators
Panel Time: December 1, 2015, 3:00 – 4:00 p.m. (Eastern)
Location: Lotte New York Palace Hotel
Details of Peregrine’s Roth Capital Partners conference participation are as follows:
Conference: Roth Capital Partners Immuno-Oncology Corporate Access Day
Date: December 16, 2015
Location: Park Hyatt New York Hotel
Yes I was... Took a bit but found it... Thanks!
"I had the opportunity to visit with investigators in the SUNRISE trial, and I continue to see enthusiasm from the sites as well as a very positive reaction to the recent immuno-oncology combination and translational clinical data coming from the rest of the bavituximab program.".... Guess I was kinda wrong..
Krak... Didn't SK make this statement in one of the quarterly conference calls? I heard it somewhere.
I'm thinking what happened with ph2... Maybe the FDA is letting them keep a close eye on what's going on?... There's a first time for everything... Just a thought.
Wow.... Thank you golfho!!
Whatever happen today, I hope it's not BS... BS has been spewed all over this company for years!! Time to move on to bigger and better things..
This is exactly what I do for work... 32 years of it.... To bad I didn't live in Tustin California.. :)
Nivolumab (Opdivo) has a long tv commercial... Hope one day we see a Bavi commercial.
Wow volgoat.... I like the thought of that... Makes me want to keep buying... Pphm buying is my hobby..
Well if you really think about it... It definitely should be another year unless Bavi fails in PH3.... If not, our 1st drug brought to market??... Yup a few billion is my thought... Especially if it's gonna be used in several other indications...
Like I said Lem... Stick around for another year... Imho, buy now... Pphm will be a 4-6 billion company by then.
Plus your not gonna get treatments on Thanksgiving day and Christmas day... I very much doubt it.... They work your treatments around the holidays.... I went thru 6 months of treatments... Plus family members would understand if they can't have Christmas day at grandma's house or at a parents house this year... Love and health will make them all understand.... Can you imagine a father, mother or grandparent say.... I'm gonna put off my treatments till after new years... If family members agree to that, there's a big problem.